{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:21:56Z","timestamp":1773285716063,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1016\/j.vaccine.2010.03.064","type":"journal-article","created":{"date-parts":[[2010,4,19]],"date-time":"2010-04-19T04:49:08Z","timestamp":1271652548000},"page":"4086-4090","source":"Crossref","is-referenced-by-count":17,"title":["Immunogenicity and safety study of Indirab: A Vero cell based chromatographically purified human rabies vaccine"],"prefix":"10.1016","volume":"28","author":[{"given":"Gadey","family":"Sampath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shampur Narayan","family":"Madhusudana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mysore Kalappa","family":"Sudarshan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doddabele Hanumanthaiah","family":"Ashwathnarayana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bangalore Jayakrishna","family":"Mahendra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thankappan P.","family":"Ullas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krishna","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santhosh Kumar","family":"Madhusudhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haradanahalli Shankariah","family":"Ravish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.03.064_bib1","series-title":"World survey of rabies No 35 for the year 1999","author":"World Health Organization","year":"2002"},{"issue":"1","key":"10.1016\/j.vaccine.2010.03.064_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ijid.2005.10.007","article-title":"Assessing burden of human rabies in India: results of a national multi-center epidemiological survey","volume":"11","author":"Sudarshan","year":"2007","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.03.064_bib3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1006\/biol.1998.0156","article-title":"Immunogenicity and safety in adults of a new chromatographically purified vero-cell rabies vaccine (CPRV): a randomized double blind trial with purified vero cell rabies vaccine (PVRV)","volume":"26","author":"Lang","year":"1998","journal-title":"Biologicals"},{"key":"10.1016\/j.vaccine.2010.03.064_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0001-706X(99)00092-3","article-title":"Immunogenicity and effectiveness of post-exposure rabies prophylaxis with a new chromatographically purified vero-cell rabies vaccine (CPRV): a two stage randomized clinical trial in the Philippines","volume":"75","author":"Quiambao","year":"2000","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2010.03.064_bib5","series-title":"Laboratory techniques in rabies","first-page":"181","article-title":"A rapid fluorescent focus inhibition test (RFFIT) for determining rabies-neutralizing antibody","author":"Smith","year":"1996"},{"key":"10.1016\/j.vaccine.2010.03.064_bib6","series-title":"WHO expert committee on biological standardization 37th report. WHO Tech Rep Ser 760","author":"World Health Organization","year":"1987"},{"key":"10.1016\/j.vaccine.2010.03.064_bib7","first-page":"27","article-title":"Polio and rabies vaccines produced in continuous cell lines. A reality for vero cell line","volume":"70","author":"Montagnon","year":"1989","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2010.03.064_bib8","series-title":"WHO expert committee on rabies: 8th report. WHO Tech Rep Ser 824","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.vaccine.2010.03.064_bib9","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/101053958800200308","article-title":"Acceptability and efficacy of purified vero-cell rabies vaccine in Thai children","volume":"2","author":"Chutivongse","year":"1988","journal-title":"Asia Pac J Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2010.03.064_bib10","first-page":"229","article-title":"Post-exposure prophylaxis of purified vero cell rabies vaccine (PVRV) during pregnancy: safety and immunogenicity study","volume":"31","author":"Sudarshan","year":"1999","journal-title":"J Commun Dis"},{"key":"10.1016\/j.vaccine.2010.03.064_bib11","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.vaccine.2004.08.001","article-title":"An immunogenicity study of a newly introduced vero cell rabies vaccine (Abhayrab) manufactured in India","volume":"23","author":"Sampath","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.03.064_bib12","first-page":"683","article-title":"Antibody response in patients after post-exposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified vero-cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull World Health Org"},{"key":"10.1016\/j.vaccine.2010.03.064_bib13","series-title":"43rd report WHO Tech rep Ser 840","article-title":"Requirements for rabies vaccines for human use produced in continuous cell lines (amendment 1992) WHO expert committee on biological Standardization","author":"World Health Organization","year":"1992"},{"key":"10.1016\/j.vaccine.2010.03.064_bib14","series-title":"Expert consultation on rabies 2004. WHO Tech Rep Ser, 931","author":"World Health Organization","year":"2005"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10004640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10004640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T15:20:22Z","timestamp":1544541622000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10004640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":14,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0264410X10004640"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.03.064","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}